CFDE Data Portal | Search ZDHHC8BP

	Label	Description
	ZDHHC8BP Gene (Entity type)	ENSG00000290920 - ZDHHC8B, pseudogene
	GSE202434 GSE202438 talazoparib 6 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 11 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239688 canagliflozin 4 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE157109 TRIM8 knockdown MCF-7 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 8 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE151083 enzalutamide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

ZDHHC8BP

ENSG00000290920 - ZDHHC8B, pseudogene

GSE202434 GSE202438 talazoparib 6 v 11 human up

A Gene Set from LINCS

GSE108464 AZ-628 11 v 12 human up

A Gene Set from LINCS

GSE48812 sulforaphane 2 v 5 human up

A Gene Set from LINCS

GSE232944 APC CTNNB1 overexpression HT29 1 v 3 human dn

A Gene Set from LINCS

GSE239688 canagliflozin 4 v 3 human dn

A Gene Set from LINCS

GSE157109 TRIM8 knockdown MCF-7 0 v 1 human dn

A Gene Set from LINCS

GSE135514 dasatinib 8 v 9 human up

A Gene Set from LINCS

GSE151083 enzalutamide 0 v 1 human up

A Gene Set from LINCS

GSE225901 dexamethasone 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.